CAH
48
-5
COF
60
2
LEG
36
4
HPQ
63
6
KEY
46
3
CMG
72
5
UPS
60
9
R
71
4
ES
34
3
MET
72
5
STZ
54
-3
HBI
59
4
VMC
57
4
BWA
48
2
CFG
70
6
WFC
79
4
MHK
49
4
BK
74
2
FLR
58
3
NAVI
52
5
CAH
48
-5
COF
60
2
LEG
36
4
HPQ
63
6
KEY
46
3
CMG
72
5
UPS
60
9
R
71
4
ES
34
3
MET
72
5
STZ
54
-3
HBI
59
4
VMC
57
4
BWA
48
2
CFG
70
6
WFC
79
4
MHK
49
4
BK
74
2
FLR
58
3
NAVI
52
5
Financhill
Back

Immuneering 10K Form

Sell
42

IMRX
Immuneering

Last Price:
2.10
Seasonality Move:
-27.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMRX News And Ratings

See the #1 stock for the next 7 days that we like better than IMRX

IMRX Financial Statistics

Sales & Book Value

Annual Sales: $316.95K
Cash Flow: $-13.48M
Price / Cash Flow: 0
Annual Sales: $1.86
Price / Book: 1.13

Profitability

EPS (TTM): -1.97000
Net Income (TTM): $-58.07M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Immuneering Earnings Forecast

Key Immuneering Financial Ratios

  • The Selling, General & Administrative Expenses for IMRX have been equal to 4,924.12% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Immuneering Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMRX
Website: immuneering.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMRX Technical Analysis vs Fundamental Analysis

Sell
42
Immuneering (IMRX) is a Sell

Is Immuneering a Buy or a Sell?

  • Immuneering stock is rated a Sell
    The current Immuneering [IMRX] share price is $2.10. The Score for IMRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.